Literature DB >> 19947883

Properdin: emerging roles of a pattern-recognition molecule.

Claudia Kemper1, John P Atkinson, Dennis E Hourcade.   

Abstract

Complement is an innate immune system that is a first line of defense against pathogens and facilitates elimination of apoptotic and injured cells. During complement activation, the complement convertases are assembled on target surfaces and initiate their proteolytic activities, a process that marks targets for phagocytosis and/or lysis. The complement alternative activation pathway has been implicated in a number of autoimmune conditions including arthritis and age-related macular degeneration. Properdin, a plasma component that is also released by activated neutrophils, is critical in the stabilization of alternative pathway convertases. Recently, it has been shown that properdin is also a pattern-recognition molecule that binds to certain microbial surfaces, apoptotic cells, and necrotic cells. Once bound to a surface, properdin can direct convertase formation and target uptake. New studies are now focusing on a role for properdin in inflammatory and autoimmune diseases. This review examines the new properdin findings and their implications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19947883     DOI: 10.1146/annurev-immunol-030409-101250

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  86 in total

1.  Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement.

Authors:  Viviana P Ferreira; Claudio Cortes; Michael K Pangburn
Journal:  Immunobiology       Date:  2010-02-12       Impact factor: 3.144

Review 2.  Complement control protein factor H: the good, the bad, and the inadequate.

Authors:  Viviana P Ferreira; Michael K Pangburn; Claudio Cortés
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

3.  Native properdin binds to Chlamydia pneumoniae and promotes complement activation.

Authors:  Claudio Cortes; V P Ferreira; Michael K Pangburn
Journal:  Infect Immun       Date:  2010-12-06       Impact factor: 3.441

4.  C1q protein binds to the apoptotic nucleolus and causes C1 protease degradation of nucleolar proteins.

Authors:  Yitian Cai; Boon Heng Dennis Teo; Joo Guan Yeo; Jinhua Lu
Journal:  J Biol Chem       Date:  2015-07-31       Impact factor: 5.157

5.  Anti-mouse properdin TSR 5/6 monoclonal antibodies block complement alternative pathway-dependent pathogenesis.

Authors:  Paula Bertram; Antonina M Akk; Hui-fang Zhou; Lynne M Mitchell; Christine T N Pham; Dennis E Hourcade
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-02

6.  Properdin homeostasis requires turnover of the alternative complement pathway.

Authors:  Xiaobo Wu; Thomas Q Xu; John P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

7.  Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin.

Authors:  Martín Alcorlo; Agustín Tortajada; Santiago Rodríguez de Córdoba; Oscar Llorca
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-30       Impact factor: 11.205

8.  Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?

Authors:  Guido Moll; Jessica J Alm; Lindsay C Davies; Lena von Bahr; Nina Heldring; Lillemor Stenbeck-Funke; Osama A Hamad; Robin Hinsch; Lech Ignatowicz; Matthew Locke; Helena Lönnies; John D Lambris; Yuji Teramura; Kristina Nilsson-Ekdahl; Bo Nilsson; Katarina Le Blanc
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

9.  Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice.

Authors:  Takashi Miwa; Sayaka Sato; Damodar Gullipalli; Masaomi Nangaku; Wen-Chao Song
Journal:  J Immunol       Date:  2013-02-20       Impact factor: 5.422

10.  Secondary cell wall polymers of Enterococcus faecalis are critical for resistance to complement activation via mannose-binding lectin.

Authors:  Stefan Geiss-Liebisch; Suzan H M Rooijakkers; Agnieszka Beczala; Patricia Sanchez-Carballo; Karolina Kruszynska; Christian Repp; Tuerkan Sakinc; Evgeny Vinogradov; Otto Holst; Johannes Huebner; Christian Theilacker
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.